Low C-Reactive Protein Levels in a Traditional West-African Population Living in a Malaria Endemic Area

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Eriksson, Ulrika K ^a   van Bodegom, David ^a,b   May, Linda ^a   Boef, Anna G C ^a   Westendorp, Rudi G J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Leyden Academy on Vitality and Ageing   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DUTCH; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GHANAIAN; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; INNATE IMMUNITY; MALARIA; MALE; NORMAL HUMAN; PARASITE LOAD; PLASMODIUM FALCIPARUM; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; WEST AFRICAN;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-REACTIVE PROTEIN; CHILD; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GHANA; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; YOUNG ADULT;

EID: 84880766572     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070076     Document Type: Article

References (49)

1. Casanova JL, Abel L, (2005) Inborn errors of immunity to infection: the rule rather than the exception. J Exp Med 202: 197-201 jem.20050854 [pii];10.1084/jem.20050854 [doi].
2. Barreiro LB, Quintana-Murci L, (2010) From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat Rev Genet 11: 17-30 nrg2698 [pii];10.1038/nrg2698 [doi].
3. Omran AR, (1971) The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q 49: 509-538.
4. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, et al. (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908: 244-254.
5. Ross R, (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126 10.1056/NEJM199901143400207 [doi].
6. Williams CG, (1957) Pleiotropy, Natural Selection, and the Evolution of Senescence. Evolution 11: 398-411.
7. Finch CE, (2010) Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc Natl Acad Sci U S A 107Suppl 1: 1718-1724 0909606106 [pii];10.1073/pnas.0909606106 [doi].
8. Du Clos TW, Mold C, (2004) C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30: 261-277 IR:30:3:261 [pii];10.1385/IR:30:3:261 [doi].
9. Aronson D, Bartha P, Zinder O, Kerner A, Markiewicz W, et al. (2004) Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 28: 674-679 10.1038/sj.ijo.0802609 [doi];0802609 [pii].
10. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. (2010) C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375: 132-140 S0140-6736(09)61717-7 [pii];10.1016/S0140-6736(09)61717-7 [doi].
11. Timpson NJ, Nordestgaard BG, Harbord RM, Zacho J, Frayling TM, et al. (2011) C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization. Int J Obes (Lond) 35: 300-308 ijo2010137 [pii];10.1038/ijo.2010.137 [doi].
12. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, et al. (2009) Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302: 37-48 302/1/37 [pii];10.1001/jama.2009.954 [doi].
13. Paul R, Sinha PK, Bhattacharya R, Banerjee AK, Raychaudhuri P, et al. (2012) Study of C reactive protein as a prognostic marker in malaria from Eastern India. Adv Biomed Res 1: 41 10.4103/2277-9175.100140 [doi];ABR-1-41 [pii].
14. O'Donnell A, Fowkes FJ, Allen SJ, Imrie H, Alpers MP, et al. (2009) The acute phase response in children with mild and severe malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 103: 679-686 S0035-9203(09)00123-0 [pii];10.1016/j.trstmh.2009.03.023 [doi].
15. Pennington R, Gatenbee C, Kennedy B, Harpending H, Cochran G, (2009) Group differences in proneness to inflammation. Infect Genet Evol 9: 1371-1380 S1567-1348(09)00212-3 [pii];10.1016/j.meegid.2009.09.017 [doi].
16. Young CJ, Gaston RS, (2000) Renal transplantation in black Americans. N Engl J Med 343: 1545-1552 10.1056/NEJM200011233432107 [doi].
17. Nair S, Eustace J, Thuluvath PJ, (2002) Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 359: 287-293 S0140-6736(02)07494-9 [pii];10.1016/S0140-6736(02)07494-9 [doi].
18. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, et al. (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2: 560-567.
19. Van Dyke AL, Cote ML, Wenzlaff AS, Land S, Schwartz AG, (2009) Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies. Cytokine 46: 236-244 S1043-4666(09)00065-9 [pii];10.1016/j.cyto.2009.02.003 [doi].
20. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, et al. (2005) Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 46: 464-469 S0735-1097(05)01042-9 [pii];10.1016/j.jacc.2005.04.051 [doi].
21. van Bodegom D, May L, Kuningas M, Kaptijn R, Thomese F, et al. (2009) Socio-economic status by rapid appraisal is highly correlated with mortality risks in rural Africa. Trans R Soc Trop Med Hyg 103: 795-800 S0035-9203(08)00544-0 [pii];10.1016/j.trstmh.2008.12.003 [doi].
22. Ghana Health Service (2004) Upper East Regional Health Administration Annual Report 2004.
23. Ghana Demographic and Health Survey. Ghana Statistical Service, Accra, Ghana; Noguchi memorial Institute for Medical Research, Legon, Ghana; ORC Macro, Calverton, MA, USA, (2003).
24. Koopman JJ, van Bodegom D, Jukema JW, Westendorp RG, (2012) Risk of cardiovascular disease in a traditional African population with a high infectious load: a population-based study. PLoS One 7: e46855 10.1371/journal.pone.0046855 [doi];PONE-D-12-15457 [pii].
25. Verweij JJ, Brienen EA, Ziem J, Yelifari L, Polderman AM, et al. (2007) Simultaneous detection and quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am J Trop Med Hyg 77: 685-690. 77/4/685 [pii].
26. Verweij JJ, Schinkel J, Laeijendecker D, van Rooyen MA, van Lieshout L, et al. (2003) Real-time PCR for the detection of Giardia lamblia. Mol Cell Probes 17: 223-225. S0890850803000574 [pii].
27. Wiria AE, Prasetyani MA, Hamid F, Wammes LJ, Lell B, et al. (2010) Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis 10: 77 1471-2334-10-77 [pii];10.1186/1471-2334-10-77 [doi].
28. Boef AG, May L, van Bodegom D, Kuningas M, Eriksson UK, et al. (2012) The influence of genetic variation on innate immune activation in an environment with high infectious pressure. Genes Immun 13: 103-108 gene201157 [pii];10.1038/gene.2011.57 [doi].
29. Blom JW, Doggen CJ, Osanto S, Rosendaal FR, (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293: 715-722 293/6/715 [pii];10.1001/jama.293.6.715 [doi].
30. Pomp ER, Le Cessie S, Rosendaal FR, Doggen CJ, (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol 139: 289-296 BJH6780 [pii];10.1111/j.1365-2141.2007.06780.x [doi].
31. Huddleston DJ, Deitrick CL, Budrean SA, Katholi RE, (2001) Performance Characteristics of an Automated Method for High-sensitivity CRP on the Roche Cobas Mira Analyzer. Journal of the Association for Laboratory Automation 6: 30-31.
32. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, et al. (2001) Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47: 426-430.
33. Jakobsen PH, McKay V, N'Jie R, Olaleye BO, D'Alessandro U, et al. (1998) Decreased antitoxic activities among children with clinical episodes of malaria. Infect Immun 66: 1654-1659.
34. Naik P, Voller A, (1984) Serum C-reactive protein levels and falciparum malaria. Trans R Soc Trop Med Hyg 78: 812-813.
35. Hurt N, Smith T, Teuscher T, Tanner M, (1994) Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity. Clin Diagn Lab Immunol 1: 437-444.
36. McGuire W, D'Alessandro U, Olaleye BO, Thomson MC, Langerock P, et al. (1996) C-reactive protein and haptoglobin in the evaluation of a community-based malaria control programme. Trans R Soc Trop Med Hyg 90: 10-14.
37. Imrie H, Fowkes FJ, Michon P, Tavul L, Reeder JC, et al. (2007) Low prevalence of an acute phase response in asymptomatic children from a malaria-endemic area of Papua New Guinea. Am J Trop Med Hyg 76: 280-284. 76/2/280 [pii].
38. Hurt N, Smith T, Tanner M, Mwankusye S, Bordmann G, et al. (1994) Evaluation of C-reactive protein and haptoglobin as malaria episode markers in an area of high transmission in Africa. Trans R Soc Trop Med Hyg 88: 182-186.
39. Israelsson E, Ekstrom M, Nasr A, Dolo A, Kearsley S, et al. (2009) Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa. Malar J 8: 136 1475-2875-8-136 [pii];10.1186/1475-2875-8-136 [doi].
40. McAdams MA, Van Dam RM, Hu FB, (2007) Comparison of self-reported and measured BMI as correlates of disease markers in US adults. Obesity (Silver Spring) 15: 188-196 15/1/188 [pii];10.1038/oby.2007.504 [doi].
41. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, et al. (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54: 1027-1037 clinchem.2007.098996 [pii];10.1373/clinchem.2007.098996 [doi].
42. Nazmi A, Victora CG, (2007) Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health 7: 212 1471-2458-7-212 [pii];10.1186/1471-2458-7-212 [doi].
43. Shah T, Newcombe P, Smeeth L, Addo J, Casas JP, et al. (2010) Ancestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circ Cardiovasc Genet 3: 436-444 CIRCGENETICS.110.957431 [pii];10.1161/CIRCGENETICS.110.957431 [doi].
44. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, et al. (2001) Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154: 681-689. S0021915000005864 [pii].
45. MacGregor AJ, Gallimore JR, Spector TD, Pepys MB, (2004) Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50: 130-134 10.1373/clinchem.2003.028258 [doi];clinchem.2003.028258 [pii].
46. Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, et al. (2010) Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci U S A 107: 786-791 0909559107 [pii];10.1073/pnas.0909559107 [doi].
47. Ding K, Kullo IJ, (2009) Evolutionary genetics of coronary heart disease. Circulation 119: 459-467 119/3/459 [pii];10.1161/CIRCULATIONAHA.108.809970 [doi].
48. Deeg M, Baiyewu O, Gao S, Ogunniyi A, Shen J, et al. (2008) A comparison of cardiovascular disease risk factor biomarkers in African Americans and Yoruba Nigerians. Ethn Dis 18: 427-433.
49. Doumatey AP, Lashley KS, Huang H, Zhou J, Chen G, et al. (2010) Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans. Obesity (Silver Spring) 18: 598-603 oby2009322 [pii];10.1038/oby.2009.322 [doi].